Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Post by fourtwentyon Feb 03, 2021 11:07am
312 Views
Post# 32458158

Why is Aphria share price lagging so far behind Tilray?

Why is Aphria share price lagging so far behind Tilray?A similar question asked before but rephrased.  Why is Aphria's share price lagging so far behind tilray?  Is there that much concern the deal might not go through?  Based on the ratio of the deal APHA should be trading at roughly 843% of Tilray ($23.71USD) but instead it is trading at $17.18USD.  That's a massive spread so I was wondering if anyone has insight into why the spread is so high?

Are there real concerns the deal won't go through?
<< Previous
Bullboard Posts
Next >>